Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003728priorityCriticalpatent/ECSP003728A/en
Publication of ECSP003728ApublicationCriticalpatent/ECSP003728A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención proporciona el uso de agonistas selectivos de RARg para la fabricación de un medicamento que contenga uno o más de tales agonistas para el tratamiento del enfisema y otras enfermedades asociadas con la lesión alveolar. En otro aspecto, la presente invención proporciona el uso de agonistas, preferentemente agonistas selectivos para RARg, para la fabricación de medicamentos para promover la expresión del gen de la tropoelastina y la reparación de la matriz alveolar.The present invention provides the use of selective RARg agonists for the manufacture of a medicament containing one or more such agonists for the treatment of emphysema and other diseases associated with alveolar lesion. In another aspect, the present invention provides the use of agonists, preferably selective agonists for RARg, for the manufacture of medicaments to promote tropoelastin gene expression and alveolar matrix repair.
ECSP0037282000-10-192000-10-19
USE OF SELECTIVE RETINOID RAR AGONISTS FOR THE DISEASE TREATMENT
ECSP003728A
(en)
Compounds derived from 1- (benzo [d] [1,3] dioxol-6-yl] -n (1h-indol-5-yl) cyclopropane carboxamide; abc modulators; pharmaceutical composition comprising them; in vitro method of increasing abc transporters; pharmaceutical kit; and its use in the treatment of cystic fibrosis, metabolic problems, of the snc, among others.
PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND FIBRATE AND ITS USE IN THE PREPARATION OF DRUGS INTENDED TO REDUCE HYPERGLYCEMIA.
PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER
Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
PRODUCT INCLUDING MIKANOLIDO, DIHIDROMIKANOLIDO OR ANALOGS OF THE SAME IN COMBINATION WITH ANOTHER ANTI-TARGET AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER